Your browser doesn't support javascript.
loading
Proficiency testing of PIK3CA mutations in HR+/HER2-breast cancer on liquid biopsy and tissue.
Vollbrecht, Claudia; Hoffmann, Inga; Lehmann, Annika; Merkelbach-Bruse, Sabine; Fassunke, Jana; Wagener-Ryczek, Svenja; Ball, Markus; Dimitrova, Lora; Hartmann, Arndt; Stöhr, Robert; Erber, Ramona; Weichert, Wilko; Pfarr, Nicole; Bohlmann, Lisa; Jung, Andreas; Dietmaier, Wolfgang; Dietel, Manfred; Horst, David; Hummel, Michael.
Afiliación
  • Vollbrecht C; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Institute of Pathology, Berlin, Germany. claudia.vollbrecht@charite.de.
  • Hoffmann I; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Institute of Pathology, Berlin, Germany.
  • Lehmann A; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Institute of Pathology, Berlin, Germany.
  • Merkelbach-Bruse S; Faculty of Medicine and University Hospital Cologne, Institute of Pathology, University of Cologne, Cologne, Germany.
  • Fassunke J; Faculty of Medicine and University Hospital Cologne, Institute of Pathology, University of Cologne, Cologne, Germany.
  • Wagener-Ryczek S; Faculty of Medicine and University Hospital Cologne, Institute of Pathology, University of Cologne, Cologne, Germany.
  • Ball M; Faculty of Medicine and University Hospital Cologne, Institute of Pathology, University of Cologne, Cologne, Germany.
  • Dimitrova L; Quality in Pathology (QuIP GmbH), Berlin, Germany.
  • Hartmann A; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Comprehensive Cancer Center Erlangen-EMN, 91054, Erlangen, Germany.
  • Stöhr R; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Comprehensive Cancer Center Erlangen-EMN, 91054, Erlangen, Germany.
  • Erber R; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Comprehensive Cancer Center Erlangen-EMN, 91054, Erlangen, Germany.
  • Weichert W; Institute of Pathology, Technical University Munich, Munich, Germany.
  • Pfarr N; Institute of Pathology, Technical University Munich, Munich, Germany.
  • Bohlmann L; Pathologisches Institut of the Ludwig-Maximilian-Universität München, Munich, Germany.
  • Jung A; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
  • Dietmaier W; Pathologisches Institut of the Ludwig-Maximilian-Universität München, Munich, Germany.
  • Dietel M; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
  • Horst D; Institute of Pathology, University of Regensburg, Regensburg, Germany.
  • Hummel M; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Institute of Pathology, Berlin, Germany.
Virchows Arch ; 482(4): 697-706, 2023 Apr.
Article en En | MEDLINE | ID: mdl-36367572
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Límite: Female / Humans País/Región como asunto: Europa Idioma: En Revista: Virchows Arch Asunto de la revista: BIOLOGIA MOLECULAR / PATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Límite: Female / Humans País/Región como asunto: Europa Idioma: En Revista: Virchows Arch Asunto de la revista: BIOLOGIA MOLECULAR / PATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Alemania